<DOC>
	<DOCNO>NCT02670304</DOCNO>
	<brief_summary>Letrozole one kind aromatase inhibitor may effect decrease estrogen luteal phase inhibit luteal function ovary . In 2009 , Letrozole report one candidate treatment prevention ovarian hyperstimulation syndrome .</brief_summary>
	<brief_title>Preventive Application Letrozole Decrease Incidence Early Onset OHSS</brief_title>
	<detailed_description>Letrozole prove effective decrease estradiol level luteal phase ovum pick . In randomize controlled study , investigator try observe effectiveness letrozole decrease incidence early ovarian hyperstimulation syndrome vascular epithelium growth factor level woman high ovarian hyperstimulation syndrome risk .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>infertile woman undergo IVF treatment 25 oocyte collect . letrozole contraindication , e.g . severe hepatic renal dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>letrozole</keyword>
	<keyword>ovarian hyperstimulating syndrome</keyword>
</DOC>